Fap.alpha.-specific antibody with improved producibility
CA 2327586 C · Owner: Saldanha, Jose · Inventors: Saldanha, Jose; Rettig, Wolfgang J.; Leger, Olivier
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Recombinant antibody proteins are provided that specifically bind fibroblast activation protein alpha (FAP.alpha.) and comprise framework modifications resulting in the improved producibility in host cells. The invention also relates to the use of said antibodies for diagnostic and therapeutic purposes and methods of producing said antibodies.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 22, 1999 and granted February 26, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 22, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 22, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.